A multi-marker molecular signature approach for treatment-specific subgroup identification with survival outcomes
{{output}}
Delivering on the promise of personalized medicine has become a focus of the pharmaceutical industry as the era of the blockbuster drug is fading. Central to realizing this promise is the need for improved analytical strategies for effectively integrating info... ...
